Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSA | P10619 | 20/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | MME | P08473 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15636556 | 0.93 | CTSA (0.59) | CTSACYP3A4MME | |
| SCHEMBL15636493 | 0.92 | CTSA (0.54) | CTSACYP3A4MME | |
| SCHEMBL15636240 | 0.91 | CTSA (0.54) | CTSACYP3A4MME | |
| SCHEMBL16223771 | 0.88 | CTSA (0.51) | CTSACYP3A4MME | |
| SCHEMBL15636817 | 0.88 | CTSA (0.49) | CTSACYP3A4MME | |
| SCHEMBL15636659 | 0.86 | CTSA (0.57) | CTSACYP3A4MME | |
| SCHEMBL15637488 | 0.86 | CTSA (0.57) | CTSACYP3A4MME | |
| SCHEMBL15636548 | 0.86 | CTSA (0.48) | CTSACYP3A4MME | |
| SCHEMBL15636840 | 0.86 | CTSA (0.58) | CTSA | |
| SCHEMBL16223840 | 0.86 | CTSA (0.58) | CTSA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2826772-A1 | Intermediates for the synthesis of oxygen-substituted 3-heteroaroylamino-propionic acid derivatives | SANOFI (FR) | 2015-01-21 | — | — | EP | disclosed |
| EP-2528902-B1 | OXYGEN-SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS | SANOFI SA (FR) | 2014-11-12 | — | — | EP | disclosed |
| WO-2014053533-A1 | USE OF SUBSTITUTED 3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AS PHARMACEUTICALS FOR PREVENTION/TREATMENT OF ATRIAL FIBRILLATION | SANOFI (FR) | 2014-04-10 | — | — | WO | disclosed |